Tcf4 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| TCF4 Gene | |
|---|---|
| Full Name | Transcription Factor 4 |
| Chromosome | 18q21.2 |
| NCBI Gene ID | 6981 |
| OMIM | 604275 |
| Ensembl ID | ENSG00000196628 |
| UniProt ID | Q9UJL9 |
| Encoded Protein | TCF4 |
| Associated Diseases | Pitt-Hopkins Syndrome, intellectual disability, autism spectrum disorder, schizophrenia |
The TCF4 gene (Transcription Factor 4) encodes a basic helix-loop-helix (bHLH) transcription factor that is essential for neuronal development, synaptic plasticity, and cognitive function. TCF4 is one of the most frequently mutated genes in Pitt-Hopkins syndrome and has been implicated in schizophrenia, autism, and neurodegenerative diseases including Alzheimer's disease and Parkinson's disease.
TCF4 is a basic helix-loop-helix (bHLH) transcription factor that plays critical roles in neurodevelopment, synaptic plasticity, and neuronal differentiation. It regulates gene expression by binding to E-box motifs (CANNTG) in promoter and enhancer regions of target genes.
High expression in developing brain, particularly in the cortex, hippocampus, and cerebellum. In adult brain, expressed in neuronal progenitor cells and post-mitotic neurons.
TCF4 haploinsufficiency causes Pitt-Hopkins syndrome, a neurodevelopmental disorder characterized by intellectual disability, absent speech, microcephaly, and characteristic facial features. TCF4 dysfunction may contribute to neurodegeneration through impaired neurogenesis and synaptic function.
TCF4 functions as a transcriptional regulator by forming homodimers or heterodimers with other bHLH proteins such as ASCL1, NEUROD1, and TCF12. These complexes bind to E-box DNA sequences (CANNTG) to activate or repress gene transcription. In the developing brain, TCF4 regulates genes involved in:
TCF4 interacts with several signaling pathways including Wnt/β-catenin, Notch, and BMP signaling to coordinate brain development. Dysregulation of these interactions contributes to neurodevelopmental disorders.
Targeting TCF4 signaling has potential therapeutic applications:
Research is ongoing to develop TCF4-targeted interventions for neurodevelopmental and neurodegenerative disorders.
Current research focuses on:
The study of Tcf4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
TCF4 functions as a transcriptional regulator by forming homodimers or heterodimers with other bHLH proteins such as ASCL1, NEUROD1, and TCF12. These complexes bind to E-box DNA sequences (CANNTG) to activate or repress gene transcription. In the developing brain, TCF4 regulates genes involved in:
TCF4 interacts with several signaling pathways including Wnt/β-catenin, Notch, and BMP signaling to coordinate brain development. Dysregulation of these interactions contributes to neurodevelopmental disorders.
Targeting TCF4 signaling has potential therapeutic applications:
Research is ongoing to develop TCF4-targeted interventions for neurodevelopmental and neurodegenerative disorders.
Current research focuses on: